Artrya

Artrya is an AI-driven MedTech company specializing in rapid assessment of coronary artery disease (CAD) through advanced diagnostic software. Founded in 2019 and based in Perth, Australia, the company develops Artrya Salix, a patented AI diagnostic support solution that analyzes arterial plaque characteristics in real-time from coronary computed tomography angiography (CCTA) scans. The platform enables healthcare professionals to stratify chest pain patients within minutes, supporting evidence-based clinical decision-making in emergency and primary care settings. By integrating machine learning for precise plaque characterization and risk stratification, Artrya helps healthcare systems reduce unnecessary patient admissions, minimize diagnostic testing costs, and prevent major adverse cardiac events. The solution supports rapid patient discharge determination and efficient patient intake workflows, transforming cardiac care delivery across clinics and global healthcare systems.